Business Wire

Dawex, Fraunhofer ISST and TNO Agree to co-Propose a Pre-Standardization Program on Trusted Data Transaction

8.2.2023 18:00:00 EET | Business Wire | Press release

Share

The French data exchange tech company Dawex, the German research organization Fraunhofer ISST and the Dutch research organization TNO, today announced they have reached an agreement to co-propose a workshop program from the European Committee for Standardization (CEN) on Trusted Data Transaction, initiating a standardization process.

To tackle economic, environmental and societal challenges, public and private organizations, large corporations and SMBs are taking full advantage of the explosion of data, and are increasingly distributing, accessing and sharing data within emerging data ecosystems. Data transactions are expected to grow exponentially in the coming years, requiring clear frameworks to organize, simplify, and secure the exchange of data, in compliance with regulatory requirements. Trust is a cornerstone of data exchange as it cements the relationship and drives collaboration between all parties involved in the data transactions.

To better understand the scope and implications of the expression of “Trusted Data Transaction” and anticipate future associated standardization requirements, a European Committee for Standardization (CEN) workshop program is being kicked off. Among its objectives are to develop terminologies, concepts, and mechanisms for common elements, starting with the groundwork on trust anchors, in order to form a foundational understanding on which trusted data transactions can be based, independent of any architectural choices or technical implementation.

Organizations interested in joining the program can express their interest by registering here, while CEN officializes the meeting schedule and kickoff time frame.

“The agreement to co-propose a European Committee for Standardization workshop program on Trusted Data Transaction, initiated by Dawex, Fraunhofer ISST and TNO, is a critical milestone to align stakeholders behind a common normative baseline that will help accelerate data exchanges across organizations, industries and geographies,” says Fabrice Tocco, Dawex co-CEO. “As other organizations join the initiative, the outcomes resulting from the collective work will serve all the use cases where stakeholders need to establish trust for the purpose of data exchange and interconnection of data spaces.”

“We are looking forward to actively engaging as co-proposer in the Trusted Data Transaction pre-standardization program, initiated by Fraunhofer ISST, Dawex and TNO. This structuring program will provide guiding principles to organizations looking at building strong data spaces in a trustworthy data economy,” said Prof. Dr.-Ing. Boris Otto, Chairman of the Fraunhofer ICT Group and Executive Director of the Fraunhofer Institute for Software and Systems Engineering ISST.

Berry Vetjens, Managing Director a.i. ICT, Strategy and Policy at TNO, added: “The Trusted Data Transaction pre-standardization workshop program will be useful to support the development of standards and contribute to the activities of European initiatives such as the Data Space Support Center by proposing a common ground to refer to.”

About Dawex

In today’s economy where data has become a product of unlimited potential, with its own value, and a source of new revenue streams, Dawex technology allows organizations to create new ecosystems around data exchange platforms that meet regulatory requirements and address traceability and security challenges. Dawex is the leading technology company for data exchange, data marketplace and data hub to orchestrate the sourcing, the distribution and the exchange of data. Awarded Technology Pioneer by the World Economic Forum in 2020, Dawex is an active member of Gaia-X. Created in 2015, Dawex is headquartered in France, expanding business operations to Europe, Asia, North America and the Middle East.

About Fraunhofer

The Fraunhofer-Gesellschaft based in Germany is the world’s leading applied research organization. Prioritizing key future-relevant technologies and commercializing its findings in business and industry, it plays a major role in the innovation process. A trailblazer and trendsetter in innovative developments and research excellence, it is helping shape our society and our future. Founded in 1949, the Fraunhofer-Gesellschaft currently operates 76 institutes and research units throughout Germany. Over 30,000 employees, predominantly scientists and engineers, work with an annual research budget of €2.9 billion. Fraunhofer generates €2.5 billion of this from contract research.

About TNO

TNO is the independent organization for applied research, based in The Netherlands. We connect people and knowledge to create innovations that sustainably strengthen the competitiveness of companies and the well-being of society. Our goal is to connect, change and accelerate: Innovation for life.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Press contact:
Isabelle Joulot, Vice President Communications & Marketing
press@dawex.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Brenus Pharma Presented New Preclinical and Early Clinical Data in Colorectal Cancer During AACR Immuno-Oncology Conference 202619.2.2026 09:50:00 EET | Press release

Brenus Pharma, a clinical-stage biotechnology company pioneering in vivo “off-the-shelf” immunotherapies, announced the selection of an abstract for a poster presentation at the American Association for Cancer Research Immuno-Oncology (AACRIO) annual conference (February 18-21, 2026), in Los Angeles. The poster showcases new preclinical data and early clinical insights from the company's lead candidate, STC-1010, supporting it as a promising therapeutic option for MSS, immune-cold colorectal cancer (CRC)—a major unmet clinical need. In a syngeneic CT26 model, murine STC-1010 significantly inhibits tumor growth and extends survival by 40%. New mechanistic datas reveal expansion of CD4⁺ and CD8⁺ T cells in draining lymph nodes alongside a significant humoral response compared to control, demonstrating coordinated cellular and humoral immune activation in vivo. Other findings show that dendritic cells efficiently capture STC-1010, leading to their activation as demonstrated by transcripto

ENHERTU ® Type II Variation Application Validated in the EU as Post-Neoadjuvant Treatment for Patients with HER2 Positive Early Breast Cancer19.2.2026 09:30:00 EET | Press release

The European Medicines Agency (EMA) has validated the Type II Variation marketing authorization application for ENHERTU® (trastuzumab deruxtecan) as a monotherapy for adult patients with HER2 positive (immunohistochemistry [IHC] 3+ or in-situ hybridization [ISH]+) breast cancer who have residual invasive disease after neoadjuvant HER2 targeted treatment. ENHERTU is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The validation confirms the completion of the application and commences the scientific review process by the EMA’s Committee for Medicinal Products for Human Use (CHMP). The application is based on data from the DESTINY-Breast05 phase 3 trial presented at the 2025 European Society for Medical Oncology (#ESMO25) Congress and subsequently published in The New England Journal of Medicine. In the trial, ENHERTU demo

NHOA Energy Advances Delivery of the 51 MWh Broni Battery for Neoen in Italy19.2.2026 09:00:00 EET | Press release

NHOA Energy, global provider of utility-scale energy storage systems, is advancing the construction of the Broni Battery, a 10 MW/51 MWh project located in Broni (Pavia), Italy, executed for Neoen, one of the world’s leading independent producers of renewable energy. Civil works at the site are currently underway and advancing on schedule, with commissioning activities planned to start in late spring 2026. Once operational, the Broni Battery will provide essential flexibility services to the Italian electricity system, supporting grid stability and reliability as renewable energy penetration continues to increase. The project represents Neoen’s first battery storage asset in Italy and marks a strategic step in the company’s expansion, as it continues to grow its battery storage portfolio in key markets worldwide to support power system flexibility. The Broni Battery further strengthens NHOA Energy’s long-term commitment to the Italian market, where the company has deep industrial roots

Compass Pathways Announces Pricing of $150 Million Public Offering19.2.2026 03:18:00 EET | Press release

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, announced today the pricing of its public offering of 17,500,000 American Depositary Shares (“ADSs”) at a public offering price of $8.00 per ADS, each representing one ordinary share, and in lieu of ADSs, to certain institutional investors, pre-funded warrants to purchase up to 1,250,000 ADSs at a public offering price of $7.9999 per pre-funded warrant. In addition, Compass Pathways has granted the underwriters a 30-day option to purchase up to an additional 2,812,500 ADSs at the public offering price, less the underwriting discounts and commissions. All of the securities are to be sold by Compass Pathways. The offering is expected to close on or about February 20, 2026, subject to the satisfaction of customary closing conditions. The gross proceeds to Compass Pathways from the offering, before deducting underwriting discounts and commissions and other est

Perpetual Atomics Ltd, QSA Europe, QSA Global and Reef Origin to Collaborate on Building Radioisotope Power Systems in Europe18.2.2026 17:44:00 EET | Press release

Perpetual Atomics Ltd, QSA Europe (a trading name of Loma Systems s.r.o.), QSA Global, Inc., and Reef Origin signed an MOU in Prague to collaborate on the industrialized production of radioisotope power systems in Europe. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260218036211/en/ Teams from Perpetual Atomics & QSA Global (USA and Czechia) at the facilities in Czechia This MOU builds on the existing collaboration between QSA Global, Inc. and Perpetual Atomics Ltd by expanding and strengthening the capacity and capability to produce radioisotope power systems in Europe. The key partnership with QSA Europe provides access to existing facilities, capabilities, knowledge, and know-how for the storage, handling, and distribution of commercial radioisotope systems for terrestrial applications. This capability is directly transferable to radioisotope power technologies for space. Radioisotope and nuclear power technologies are

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye